Â鶹´«Ã½

Skip to main content

WeightWatchers to offer compounded version of Wegovy weight-loss drug

Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (Amanda Andrade-Rhoades / AP Photo) Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (Amanda Andrade-Rhoades / AP Photo)
Share

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of its weight-management programs.

Soaring demand for weight-loss drugs such as Wegovy and Eli Lilly's Zepbound, shown to help patients lose as much as 20 per cent of weight on average, has led to their shortages that allowed drug compounders to produce them under U.S. regulations.

Multiple telehealth companies, including Noom and Hims & Hers Health, offer compounded versions of semaglutide, the chemical name of Novo's Wegovy and its diabetes drug Ozempic, as patients look for alternatives amid their shortage.

Drug compounding refers to the practice of combining, mixing or altering drug ingredients to create a medicine tailored for an individual patient's need, according to the U.S. Food and Drug Administration.

The company, also known as WW International, said the new offering would start at US$129.

Its shares were up 3.8 per cent in late-morning trading, paring early gains.

"Given the ongoing shortages of branded medications such as Ozempic and Wegovy, WeightWatchers is committed to ensuring our members still have access to effective alternatives," CEO Tara Comonte said in a statement.

Outsourcing Facilities Association, a drug compounding industry group, sued the FDA on Monday over its decision to take Eli Lilly's blockbuster weight-loss and diabetes drugs off its list of medicines in short supply last week.

Novo's Wegovy and Ozempic are still on that list.

The compounding group claimed the FDA removed Lilly's tirzepatide, the key ingredient in its drugs Mounjaro and Zepbound, from the list even though it remains in short supply.

Lilly said in August it had begun selling vials of its Zepbound at US$399 for a month's supply through its direct-to-consumer website.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shilpi Majumdar)

CTVNews.ca Top Stories

Emotions boiled over after a judge acquitted two out of three defendants in a manslaughter case, while the third accused has since died.

On September 11, 80-year-old Madeleine Gervais was robbed in Ottawa's west end. It happened in the Loblaws parking lot in College Square, when she was approached by a man and a woman who insisted to help her load her groceries into her car.

Local Spotlight

A B.C. couple is getting desperate – and creative – in their search for their missing dog.

Videos of a meteor streaking across the skies of southern Ontario have surfaced and small bits of the outer space rock may have made it to land, one astronomy professor says.

A unique form of clouds made an appearance over the skies of Ottawa on Sunday evening.

Bernie Hicks, known as the ‘Batman of Amherst,’ always wanted to sit in a Batmobile until a kind stranger made it happen.

Bubi’s Awesome Eats, located on University Ave West took to social media to announce the closure on Friday.

Weeneebayko Area Health Authority and the Government of Ontario have awarded a $1.8 billion fixed-price contract to design, build and finance a new Far North hospital.

Manitobans are in cleanup mode after intense winds barreled through southern parts of the province this weekend.

Avry Wortman, 13, scored two touchdowns on Sunday during her team's win in the under 14 Greater Moncton Football Association.

A gargantuan gourd – affectionately named ‘Orangina’ by the urban gardeners who grew it in the front yard of their Vancouver home – earned the massive honour of being named B.C.’s heaviest giant pumpkin Saturday.